Today we announced a new R21 grant from NCATS NIH awarded to Collaborations Pharmaceuticals, Inc andTexas Biomedical Research Institute. This continues the work published in F1000Research . What is missing from the press release and papers etc. is the back story. Why are we working on this and how did it start. Essentially it took …